Latest Articles

Publication Date
Endometrial cancer: new markers for PET imaging - healthcare-in-europe.com

Endometrial cancer: new markers for PET imaging healthcare-in-europe.com

Published: Sept. 7, 2025, 6:23 a.m.
Genmab (CPSE:GMAB) Is Up 10.3% After FDA Breakthrough for Rina-S in Endometrial Cancer – Has The Bull Case Changed? - Yahoo Finance

Genmab (CPSE:GMAB) Is Up 10.3% After FDA Breakthrough for Rina-S in Endometrial Cancer – Has The Bull Case Changed? Yahoo Finance

Published: Sept. 6, 2025, 11:31 a.m.
New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer - Medical Xpress

New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer Medical Xpress

Published: Sept. 5, 2025, 4:10 p.m.
HER2 and CD24 emerge as promising radiotheranostic targets in endometrial cancer - News-Medical

HER2 and CD24 emerge as promising radiotheranostic targets in endometrial cancer News-Medical

Published: Sept. 5, 2025, 4 a.m.
New Radiotheranostic Targets Discovered for Enhanced Diagnosis and Treatment of Endometrial Cancer - BIOENGINEER.ORG

New Radiotheranostic Targets Discovered for Enhanced Diagnosis and Treatment of Endometrial Cancer BIOENGINEER.ORG

Published: Sept. 4, 2025, 9:37 p.m.
New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer - EurekAlert!

New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer EurekAlert!

Published: Sept. 4, 2025, 9:25 p.m.
Closing Deadly Gaps in Endometrial Cancer Care Outcomes - Medscape

Closing Deadly Gaps in Endometrial Cancer Care Outcomes Medscape

Published: Sept. 4, 2025, 1:52 p.m.
Johor Hospital completes first robotic surgery for endometrial cancer - MSN

Johor Hospital completes first robotic surgery for endometrial cancer MSN

Published: Sept. 4, 2025, 1:14 p.m.
Age, Race Play a Role in Endometrial Cancer Outcomes - Cancer Nursing Today

Age, Race Play a Role in Endometrial Cancer Outcomes Cancer Nursing Today

Published: Sept. 3, 2025, 11:02 p.m.
The molecular role of RE1 silencing transcription factor in uterine diseases: is there potential for targeted therapeutic development?

Published: Sept. 3, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!